Clinical Trial

Study About Drug Resistance of Mycobacterium Tuberculosis

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Tuberculosis is a major cause of ill health and one of the leading causes of death worldwide. Early, rapid and accurate diagnosis of all TB patients and prompt treatment with any form of drug-susceptible or drug resistant TB is fundamental. Identifying the pattern of drug resistance will ensure that the most effective therapy can be selected. The aim of this study is to assess the prevalence and patterns of drug resistance of mycobacterium tuberculosis and to detect the possible risk factors associated with resistant cases.
Trial Details
NCT Number NCT07169149
Lead Sponsor Sohag University
Conditions Pulmonary and Extra- Pulmonary Tuberculosis (TB)
Enrollment 250 participants
Start Date 2025-10
Primary Completion 2026-08 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2025-09-11